Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICARES MedicusROCO:6612 -0.14%85 PB Ratio is 1.84 as of Aug. 15, 2026, which is 49% below its 10-year median of 3.59. GuruFocus rates ROCO:6612 with a GF Score™ of 85/100 and a GF Value™ of NT$172.38 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 783 Medical Devices & Instruments companies, ICARES Medicus ranks better than 56.07% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-15), ICARES Medicus's share price is NT$72.90. ICARES Medicus's Book Value per Share for the quarter that ended in Mar. 2026 was NT$39.68. Hence, ICARES Medicus's PB Ratio of today is 1.84.
Good Sign:
ICARES Medicus Inc stock PB Ratio (=1.84) is close to 10-year low of 1.69.
The historical rank and industry rank for ICARES Medicus's PB Ratio or its related term are showing as below:
ROCO:6612'
s PB Ratio Range Over the Past 10 Years
Min: 1.69 Med: 3.59 Max: 7.25
Current: 1.84
During the past 13 years, ICARES Medicus's highest PB Ratio was 7.25. The lowest was 1.69. And the median was 3.59.
ROCO:6612's PB Ratio is ranked better than 56.07% of 783
companies
in the Medical Devices & Instruments industry
Industry Median: 2.13
vs ROCO:6612: 1.84
During the past 12 months, ICARES Medicus's average Book Value Per Share Growth Rate was 9.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 22.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 21.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 27.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of ICARES Medicus was 267.00% per year. The lowest was 8.60% per year. And the median was 23.75% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
ICARES Medicus PB Ratio Related Terms
ICARES Medicus PB Ratio Historical Data
* Premium members only.
The historical data trend for ICARES Medicus's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ICARES Medicus's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICARES Medicus PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICARES Medicus's PB Ratio distribution charts can be found below:
* The bar in red indicates where ICARES Medicus's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
ICARES Medicus's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
ICARES Medicus (ROCO:6612) has a PB Ratio of 1.84 as of Aug. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on ICARES Medicus and its competitors. This is 49% below median its historical median of 3.59. Over the past decade, ICARES Medicus' PB Ratio has ranged from 1.69 to 7.25. According to the industry distribution chart, ICARES Medicus ranks #344 out of 783 companies in the Medical Devices & Instruments industry, placing it in the top 43.9%.
Is ICARES Medicus' PB Ratio too high?
ICARES Medicus' current PB Ratio of 1.84 is 49% below median its 10-year median of 3.59. Over the past 10 years, this metric has ranged from a low of 1.69 to a high of 7.25. The Medical Devices & Instruments industry median PB Ratio is 2.13. ICARES Medicus' value of 1.84 is 13.6% below this industry median. Based on the distribution chart, ICARES Medicus ranks #344 out of 783 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, ICARES Medicus has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ICARES Medicus' PB Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, ICARES Medicus ranks #344 out of 783 companies for PB Ratio. This puts ICARES Medicus in the upper half of its industry. The industry median PB Ratio is 2.13. ICARES Medicus' value of 1.84 is 13.6% below this benchmark. Historically, ICARES Medicus' own PB Ratio has ranged from 1.69 to 7.25 over the past decade. While the company's 10-year median is 3.59 vs. the industry median of 2.13, ICARES Medicus has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.13, based on 783 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICARES Medicus's current PB Ratio of 1.84 is 13.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on ICARES Medicus and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICARES Medicus's current PB Ratio is 1.84, which is 49% below median its own 10-year median of 3.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICARES Medicus stock overvalued right now?
Based on GuruFocus' analysis, ICARES Medicus (ROCO:6612) is currently considered Possible Value Trap. The stock's GF Value™ is NT$172.38, compared to a current price of NT$72.90 — trading 57.7% below its estimated fair value. The current PB Ratio is 1.84, which is 49% below median its 10-year median of 3.59 and 13.6% below the Medical Devices & Instruments industry median of 2.13. ICARES Medicus' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For ICARES Medicus (ROCO:6612), the current PB Ratio is 1.84 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICARES Medicus (ROCO:6612) Overvalued in 2026?
Based on GuruFocus' analysis, ICARES Medicus stock appears to be undervalued.
The current stock price of NT$72.90 is trading 57.7% below its estimated GF Value™ of NT$172.38.
GuruFocus considers ICARES Medicus to be Possible Value Trap.
Key valuation signals for ROCO:6612:
PB Ratio: 1.84 (49% below median its 10-year median of 3.59)
GF Value™: NT$172.38 vs. price of NT$72.90 (57.7% below fair value)
Industry Position: 13.6% below the Medical Devices & Instruments median (#344 of 783)
No single metric tells the full story. See the ROCO:6612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICARES Medicus Inc is engaged in providing high-grade nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices. In addition, it also designs, develops, manufactures, and sells intraocular lenses and nanomedical devices. The company's operating segments are Europe and America, which derive maximum revenue, China, and R.O.C. Geographically, it generates maximum revenue from the United States, followed by Taiwan, Spain, England, Japan, China, Germany, and other countries.
85GF Score
Get the complete analysis for ROCO:6612
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6612 has been successfully added to your 
